A review of experimental design best practices for proteomics based biomarker discovery: focus on SELDI-TOF.

Surface Enhanced Laser/Desorption Ionization-time of flight (SELDI-TOF) mass spectrometry is a technique uniquely suited to the study of the urine proteome due to its salt tolerance, high-throughput, and small sample requirements. However, due to the extreme sensitivity of the technique, sample collection and storage conditions, as well as instrument protocols and analysis conditions, must be rigorously controlled to ensure that data generated and collected is accurate and free from artifacts. Robust and reproducible data sets can be generated and compared between clinical sites when experimental protocols are carefully standardized. This chapter aims to review known factors that cause irreproducible results so that the experiments may be designed with appropriate sample and process controls for successful biomarker discovery. A suggested protocol follows the review. A number of issues for study design are discussed and these are generally applicable to biomarker discovery experiments.

[1]  O John Semmes,et al.  Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization‐time of flight (SELDI‐TOF) mass spectrometry: Multi‐institution correlation of spectra and identification of biomarkers , 2005, Proteomics.

[2]  V. Thulasiraman,et al.  Reducing protein concentration range of biological samples using solid-phase ligand libraries. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  E. Dalmasso,et al.  Contribution of Human α-Defensin 1, 2, and 3 to the Anti-HIV-1 Activity of CD8 Antiviral Factor , 2002, Science.

[4]  M. Goligorsky,et al.  Toward proteomics in uroscopy: urinary protein profiles after radiocontrast medium administration. , 2001, Journal of the American Society of Nephrology : JASN.

[5]  Juri Rappsilber,et al.  Exploring the hidden human urinary proteome via ligand library beads. , 2005, Journal of proteome research.

[6]  James Lyons-Weiler,et al.  Standards of Excellence and Open Questions in Cancer Biomarker Research: An Informatics Perspective , 2005, Cancer informatics.

[7]  H. Vyas,et al.  Understanding and managing acute fluid and electrolyte disturbances , 2003 .

[8]  E. Petricoin,et al.  Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.

[9]  T. Yip,et al.  Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. , 2003, Clinical chemistry.

[10]  N. Anderson,et al.  Analytical techniques for cell fractions. XXV. Concentration and two-dimensional electrophoretic analysis of human urinary proteins. , 1979, Analytical biochemistry.

[11]  L. Heickendorff,et al.  Diurnal variations in serum and urine markers of type I and type III collagen turnover in children. , 2001, Clinical chemistry.

[12]  Jeffrey S. Morris,et al.  Bias, Randomization, and Ovarian Proteomic Data: A Reply to “Producers and Consumers” , 2005 .

[13]  G. Ross,et al.  Early Prediction of Acute Renal Injury Using Urinary Proteomics , 2005, American Journal of Nephrology.

[14]  P. Nickerson,et al.  Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. , 2004, Kidney international.

[15]  M. Kretzler,et al.  Bioinformatic analysis of the urine proteome of acute allograft rejection. , 2004, Journal of the American Society of Nephrology : JASN.

[16]  Eric Fung,et al.  The use of SELDI ProteinChip array technology in renal disease research. , 2003, Methods in molecular medicine.

[17]  T. Libermann,et al.  Urine proteomic profiling of pediatric nephrotic syndrome , 2006, Pediatric Nephrology.

[18]  Nicolle H Packer,et al.  Simple urinary sample preparation for proteomic analysis. , 2006, Journal of proteome research.

[19]  T. Ganz.  Defensins in the urinary tract and other tissues. , 2001, The Journal of infectious diseases.

[20]  C. Kunin,et al.  The antimicrobial defense mechanism of the female urethra: a reassessment. , 2002, The Journal of urology.

[21]  Jeffrey S. Morris,et al.  Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments , 2004, Bioinform..

[22]  Ming Xu,et al.  Using tree analysis pattern and SELDI-TOF-MS to discriminate transitional cell carcinoma of the bladder cancer from noncancer patients. , 2005, European urology.

[23]  T. Libermann,et al.  SELDI‐TOF MS of quadruplicate urine and serum samples to evaluate changes related to storage conditions , 2006, Proteomics.

[24]  O John Semmes,et al.  Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.